Siegel R, Miller K, Fuchs H, Jemal A. Cancer Statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

Article  PubMed  Google Scholar 

Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-Cell Lung Cancer. Nat Rev Dis Primers. 2021;7(1):3.

Article  PubMed  PubMed Central  Google Scholar 

Bogart JA, Waqar SN, Mix MD. Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer. J Clin Oncol. 2022;40(6):661–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang S, Zhang Z, Wang Q. Emerging Therapies for Small Cell Lung Cancer. J Hematol Oncol. 2019;12(1):47.

Article  PubMed  PubMed Central  Google Scholar 

Zugazagoitia J, Paz-Ares L. Extensive-Stage Small-Cell Lung Cancer: First-Line and Second-Line Treatment Options. J Clin Oncol. 2022;40(6):671–80.

Article  CAS  PubMed  Google Scholar 

Horn L, Mansfield A, Szczęsna A, Havel L, Krzakowski M, Hochmair M, Huemer F, Losonczy G, Johnson M, Nishio M, et al. First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018;379(23):2220–9.

Article  CAS  PubMed  Google Scholar 

Paz-Ares L, Dvorkin M, Chen Y, Reinmuth N, Hotta K, Trukhin D, Statsenko G, Hochmair M, Özgüroğlu M, Ji J, et al. Durvalumab Plus Platinum-Etoposide Versus Platinum-Etoposide in First-Line Treatment of Extensive-Stage Small-Cell Lung Cancer (CASPIAN): a Randomised, Controlled, Open-Label, Phase 3 Trial. Lancet (London, England). 2019;394(10212):1929–39.

Article  CAS  PubMed  Google Scholar 

Schenk MW, Humphrey S, Hossain A, Revill M, Pearsall S, Lallo A, Brown S, Bratt S, Galvin M, Descamps T, et al. Soluble Guanylate Cyclase Signalling Mediates Etoposide Resistance in Progressing Small Cell Lung Cancer. Nat Commun. 2021;12(1):6652.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dovedi S, Adlard A, Lipowska-Bhalla G, McKenna C, Jones S, Cheadle E, Stratford I, Poon E, Morrow M, Stewart R, et al. Acquired Resistance to Fractionated Radiotherapy can be Overcome by Concurrent PD-L1 Blockade. Can Res. 2014;74(19):5458–68.

Article  CAS  Google Scholar 

Marciscano A, Ghasemzadeh A, Nirschl T, Theodros D, Kochel C, Francica B, Muroyama Y, Anders R, Sharabi A, Velarde E, et al. Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy. Clin Cancer Res. 2018;24(20):5058–71.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ban Y, Markowitz GJ, Zou Y, Ramchandani D, Kraynak J, Sheng J, Lee SB, Wong STC, Altorki NK, Gao D, et al. Radiation-Activated Secretory Proteins of Scgb1a1(+) Club Cells Increase the Efficacy of Immune Checkpoint Blockade in Lung Cancer. Nat Cancer. 2021;2(9):919–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baharom F, Ramirez-Valdez RA, Khalilnezhad A, Khalilnezhad S, Dillon M, Hermans D, Fussell S, Tobin KKS, Dutertre CA, Lynn GM, et al. Systemic Vaccination Induces CD8(+) T Cells and Remodels the Tumor Microenvironment. Cell. 2022;185(23):4317-4332.e4315.

Article  CAS  PubMed  Google Scholar 

Rao L, Zhao SK, Wen C, Tian R, Lin L, Cai B, Sun Y, Kang F, Yang Z, He L, et al. Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles. Adv Mater. 2020;32(47):e2004853.

Article  PubMed  PubMed Central  Google Scholar 

Xiong Q, Huang Z, Xin L, Qin B, Zhao X, Zhang J, Shi W, Yang B, Zhang G, Hu Y. Post-Treatment Neutrophil-to-Lymphocyte Ratio (NLR) Predicts Response to Anti-PD-1/PD-L1 Antibody in SCLC Patients at Early Phase. Cancer Immunol Immunother. 2021;70(3):713–20.

Article  CAS  PubMed  Google Scholar 

Qi WX, Xiang Y, Zhao S, Chen J. Assessment of systematic inflammatory and nutritional indexes in extensive-stage Small-Cell Lung Cancer Treated with First-Line Chemotherapy and Atezolizumab. Cancer Immunol Immunother. 2021;70(11):3199–206.

Article  CAS  PubMed  Google Scholar 

McGee HM, Daly ME, Azghadi S, Stewart SL, Oesterich L, Schlom J, Donahue R, Schoenfeld JD, Chen Q, Rao S, et al. Stereotactic Ablative Radiation Therapy Induces Systemic Differences in Peripheral Blood Immunophenotype Dependent on Irradiated Site. Int J Radiat Oncol Biol Phys. 2018;101(5):1259–70.

Article  PubMed  PubMed Central  Google Scholar 

Perisano C, Spinelli M, Graci C, Scaramuzzo L, Marzetti E, Barone C, Fabbriciani C, Maccauro G. Soft Tissue Metastases in Lung Cancer: a Review of the Literature. Eur Rev Med Pharmacol Sci. 2012;16(14):1908–14.

CAS  PubMed  Google Scholar 

Tian Y, Ma J, Jing X, Zhai X, Li Y, Guo Z, Yu J, Zhu H. Radiation Therapy for Extensive-Stage Small-Cell Lung Cancer in the Era of Immunotherapy. Cancer Lett. 2022;541:215719.

Article  CAS  PubMed  Google Scholar 

Kim EY, Cho EN, Park HS, Kim A, Hong JY, Lim S, Youn JP, Hwang SY, Chang YS. Genetic Heterogeneity of Actionable Genes Between Primary and Metastatic Tumor in Lung Adenocarcinoma. BMC Cancer. 2016;16:27.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaebe K, Li AY, Park A, Parmar A, Lok BH, Sahgal A, Chan KKW, Erickson AW, Das S. Stereotactic Radiosurgery Versus Whole Brain Radiotherapy in Patients with Intracranial Metastatic Disease and Small-Cell Lung Cancer: a Systematic Review and Meta-Analysis. Lancet Oncol. 2022;23(7):931–9.

Article  PubMed  Google Scholar 

Gong L, Xu L, Yuan Z, Wang Z, Zhao L, Wang P. Clinical Outcome for Small Cell Lung Cancer Patients with Bone Metastases at the Time of Diagnosis. J Bone Oncol. 2019;19:100265.

Article  PubMed  PubMed Central  Google Scholar 

Bhattacharya IS, Hoskin PJ. Stereotactic Body Radiotherapy for Spinal and Bone Metastases. Clin Oncol (R Coll Radiol). 2015;27(5):298–306.

Article  CAS  PubMed  Google Scholar 

Rathod S, Jeremic B, Dubey A, Giuliani M, Bashir B, Chowdhury A, Liang Y, Pereira S, Agarwal J, Koul R. Role of Thoracic Consolidation Radiation in Extensive Stage Small Cell Lung Cancer: a Systematic Review and Meta-Analysis of Randomised Controlled Trials. Eur J Cancer. 2019;110:110–9.

Article  PubMed  Google Scholar 

Gay C, Stewart C, Park E, Diao L, Groves S, Heeke S, Nabet B, Fujimoto J, Solis L, Lu W, et al. Patterns of Transcription Factor Programs and Immune Pathway Activation Define Four Major Subtypes of SCLC with Distinct Therapeutic Vulnerabilities. Cancer Cell. 2021;39(3):346-360.e347.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Käsmann L, Eze C, Manapov F. Stereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death? Int J Radiat Oncol Biol Phys. 2020;108(1):225–6.

Article  PubMed  Google Scholar 

Asamura H, Nishimura KK, Giroux DJ, Chansky K, Hoering A, Rusch V, Rami-Porta R. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer. J Thorac Oncol. 2023;18(5):564–75.

Article  PubMed  Google Scholar 

Seymour L, Bogaerts J, Perrone A, Ford R, Schwartz LH, Mandrekar S, Lin NU, Litière S, Dancey J, Chen A, et al. iRECIST: Guidelines for Response Criteria for Use in Trials Testing Immunotherapeutics. Lancet Oncol. 2017;18(3):e143–52.

Article  PubMed  PubMed Central  Google Scholar 

Tong YS, Tan J, Zhou XL, Song YQ, Song YJ. Systemic Immune-Inflammation Index Predicting chemoradiation Resistance and Poor Outcome in Patients with Stage III Non-Small Cell Lung Cancer. J Transl Med. 2017;15(1):221.

Article  PubMed  PubMed Central  Google Scholar 

Rudin CM, Poirier JT, Byers LA, Dive C, Dowlati A, George J, Heymach JV, Johnson JE, Lehman JM, MacPherson D, et al. Molecular Subtypes of Small Cell Lung Cancer: a Synthesis of Human and Mouse Model Data. Nat Rev Cancer. 2019;19(5):289–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang N, Gao Y, Huang Z, Dai P, Luo Y, Wu Q, Jiang X, Sun W, Zhang J, Han L, et al. PARP Inhibitor Plus Radiotherapy Reshapes an Inflamed Tumor Microenvironment that Sensitizes Small Cell Lung Cancer to the Anti-PD-1 Immunotherapy. Cancer Lett. 2022;545:215852.

Article  CAS  PubMed  Google Scholar 

Wang Y, Liu ZG, Yuan H, Deng W, Li J, Huang Y, Kim BYS, Story MD, Jiang W. The Reciprocity between Radiotherapy and Cancer Immunotherapy. Clin Cancer Res. 2019;25(6):1709–17.

Article  CAS  PubMed  Google Scholar 

Robin TP, Jones BL, Amini A, Koshy M, Gaspar LE, Liu AK, Nath SK, Kavanagh BD, Camidge DR, Rusthoven CG. Radiosurgery Alone is Associated with Favorable Outcomes for Brain Metastases from Small-Cell Lung Cancer. Lung Cancer. 2018;120:88–90.

Article  PubMed  Google Scholar 

Rodríguez de Dios N, Couñago F, Murcia-Mejía M, Rico-Oses M, Calvo-Crespo P, Samper P, Vallejo C, Luna J, Trueba I, Sotoca A, et al. Randomized Phase III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small-Cell Lung Cancer (PREMER): A GICOR-GOECP-SEOR Study. J Clin Oncol. 2021;39(28):3118–27.

Article  PubMed  Google Scholar 

Bilen MA, Martini DJ, Liu Y, Lewis C, Collins HH, Shabto JM, Akce M, Kissick HT, Carthon BC, Shaib WL, et al. The Prognostic and Predictive Impact of Inflammatory Biomarkers in Patients Who Have Advanced-Stage Cancer Treated with Immunotherapy. Cancer. 2019;125(1):127–34.